TransGenRx signs $30 million deal with Argentinean firm

    By
    -
    Insider

    TransGenRx, a biotech firm that spun off of research at the LSU Ag Center, has signed a $30 million deal to produce human growth hormone for a pharmaceutical company based in Argentina. Cassara will b…


    Already an INSIDER? .

    RELATED ARTICLESMORE FROM AUTHOR